Mark A. Subler

3.8k total citations
65 papers, 3.0k citations indexed

About

Mark A. Subler is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Mark A. Subler has authored 65 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 30 papers in Oncology and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Mark A. Subler's work include Cancer-related Molecular Pathways (20 papers), Cancer Mechanisms and Therapy (14 papers) and Virus-based gene therapy research (9 papers). Mark A. Subler is often cited by papers focused on Cancer-related Molecular Pathways (20 papers), Cancer Mechanisms and Therapy (14 papers) and Virus-based gene therapy research (9 papers). Mark A. Subler collaborates with scholars based in United States, Canada and Japan. Mark A. Subler's co-authors include Sumitra Deb, Daniel W. Martin, Jolene J. Windle, Raquel Muñoz, Daniel H. Conrad, Doris Brown, Chunrong Yu, Paul Dent, Mohamed Rahmani and Steven Grant and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Mark A. Subler

65 papers receiving 2.9k citations

Peers

Countries citing papers authored by Mark A. Subler

Since Specialization

Citations

This map shows the geographic impact of Mark A. Subler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Subler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Subler more than expected).

Fields of papers citing papers by Mark A. Subler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Subler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Subler. The network helps show where Mark A. Subler may publish in the future.

Co-authorship network of co-authors of Mark A. Subler

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Subler. A scholar is included among the top collaborators of Mark A. Subler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Subler. Mark A. Subler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Osteoclast-derived IGF1 induces RANKL production in osteocytes and contributes to pagetic lesion formation 2023 ·JCI Insight ·Kazuaki Miyagawa, (unknown), Patrick L. Mulcrone, Jesús Delgado‐Calle, Mark A. Subler, Jolene J. Windle, John M. Chirgwin, G. David Roodman, Noriyoshi Kurihara	6
2	Astrocyte Elevated Gene-1 Cys75 S-Palmitoylation by ZDHHC6 Regulates Its Biological Activity 2022 ·Biochemistry ·Garrison Komaniecki, (unknown), (unknown), Rachel G. Mendoza, Mark A. Subler, Jolene J. Windle, Mikhail G. Dozmorov, Zhao Lai, Devanand Sarkar, Hening Lin	13
3	Novelty-induced hyperactivity and suppressed cocaine induced locomotor activation in mice lacking threonine 53 phosphorylation of dopamine transporter 2021 ·Behavioural Brain Research ·(unknown), Mark A. Subler, Jolene J. Windle, Lankupalle D. Jayanthi, Sammanda Ramamoorthy	11
4	Astrocyte Elevated Gene-1 Regulates Macrophage Activation in Hepatocellular Carcinogenesis 2018 ·Cancer Research ·Chadia L. Robertson, Rachel G. Mendoza, Nidhi Jariwala, Mikhail G. Dozmorov, Nitai D. Mukhopadhyay, Mark A. Subler, Jolene J. Windle, Zhao Lai, Paul B. Fisher, Shobha Ghosh, Devanand Sarkar	26
5	Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma 2017 ·Cancer Research ·Nidhi Jariwala, Devaraja Rajasekaran, Rachel G. Mendoza, Xue‐Ning Shen, Ayesha Siddiq, Maaged Akiel, Chadia L. Robertson, Mark A. Subler, Jolene J. Windle, Paul B. Fisher, Arun J. Sanyal, Devanand Sarkar	50
6	IGFBP7 Deletion Promotes Hepatocellular Carcinoma 2017 ·Cancer Research ·Maaged Akiel, Chunqing Guo, Xia Li, Devaraja Rajasekaran, Rachel G. Mendoza, Chadia L. Robertson, Nidhi Jariwala, Fang Yuan, Mark A. Subler, Jolene J. Windle, Dawn Garcia, Zhao Lai, Hung-I Harry Chen, Yidong Chen, Shah Giashuddin, Paul B. Fisher, Xiang‐Yang Wang, (unknown)	50
7	Astrocyte Elevated Gene-1 (AEG-1) Regulates Lipid Homeostasis 2015 ·Journal of Biological Chemistry ·Chadia L. Robertson, Jyoti Srivastava, Ayesha Siddiq, Rachel Gredler, Luni Emdad, Devaraja Rajasekaran, Maaged Akiel, Xue‐Ning Shen, Frank Corwin, Gobalakrishnan Sundaresan, Jamal Zweit, Colleen M. Croniger, Xiaoli Gao, Shobha Ghosh, Philip B. Hylemon, Mark A. Subler, Jolene J. Windle, Paul B. Fisher, Devanand Sarkar	19
8	Genetic Deletion of AEG-1 Prevents Hepatocarcinogenesis 2014 ·Cancer Research ·Chadia L. Robertson, Jyoti Srivastava, Ayesha Siddiq, Rachel Gredler, Luni Emdad, Devaraja Rajasekaran, Maaged Akiel, Xue‐Ning Shen, Chunqing Guo, Shah Giashuddin, Xiang‐Yang Wang, Shobha Ghosh, Mark A. Subler, Jolene J. Windle, Paul B. Fisher, Devanand Sarkar	44
9	Sperm-Associated Antigen–17 Gene Is Essential for Motile Cilia Function and Neonatal Survival 2013 ·American Journal of Respiratory Cell and Molecular Biology ·María E. Teves, (unknown), Richard M. Costanzo, Scott C. Henderson, Frank Corwin, Jamal Zweit, Gobalakrishnan Sundaresan, Mark A. Subler, Fadi N. Salloum, Bruce K. Rubin, Jerome F. Strauss	40
10	Astrocyte elevated gene-1 promotes hepatocarcinogenesis: Novel insights from a mouse model 2012 ·Hepatology ·Jyoti Srivastava, Ayesha Siddiq, Luni Emdad, Prasanna K. Santhekadur, Dong Chen, Rachel Gredler, Xue‐Ning Shen, Chadia L. Robertson, Catherine I. Dumur, Phillip B. Hylemon, Nitai D. Mukhopadhyay, Deepak Bhere, Khalid Shah, Rushdy Ahmad, Shah Giashuddin, (unknown), Mark A. Subler, Jolene J. Windle, Paul B. Fisher, Devanand Sarkar	66
11	Role of LPA₄/p2y9/GPR23 in Negative Regulation of Cell Motility 2008 ·Molecular Biology of the Cell ·(unknown), (unknown), Baiyu Zhang, Mark A. Subler, Jinhua Wu, Abir Mukherjee, Jolene J. Windle, Ching‐Kang Chen, Xianjun Fang	127
12	A SQSTM1/p62 mutation linked to Paget’s disease increases the osteoclastogenic potential of the bone microenvironment 2008 ·Human Molecular Genetics ·Yuko Hiruma, Noriyoshi Kurihara, Mark A. Subler, Hua Zhou, (unknown), Heju Zhang, Seiichi Ishizuka, David W. Dempster, G. David Roodman, Jolene J. Windle	67
13	Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease 2006 ·Journal of Clinical Investigation ·Noriyoshi Kurihara, Yuko Hiruma, Hua Zhou, Mark A. Subler, David W. Dempster, Frederick R. Singer, Sakamuri V. Reddy, Helen E. Gruber, Jolene J. Windle, G. David Roodman	90
14	Induction of Apoptosis in BCR/ABL+ Cells By Histone Deacetylase Inhibitors Involves Reciprocal Effects on the RAF/MEK/ERK and JNK Pathways 2003 ·Cancer Biology & Therapy ·Chunrong Yu, Mark A. Subler, Mohamed Rahmani, (unknown), Geoffrey W. Krystal, Daniel H. Conrad, Paul Dent, Steven Grant	59
15	Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors 2000 ·Oncogene ·David J. Bearss, Mark A. Subler, (unknown), Dean A. Troyer, (unknown), Jolene J. Windle	36
16	A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis 1998 ·Molecular and Cellular Biology ·(unknown), Mark A. Subler, Elaine Rands, Charles A. Omer, (unknown), (unknown), Steven K. Koester, Dean A. Troyer, David J. Bearss, Michael W. Conner, W. Wayt Gibbs, Kelly Hamilton, Kenneth S. Koblan, Scott D. Mosser, Timothy J. O’Neill, Michael D. Schaber, (unknown), Jolene J. Windle, Allen Oliff, Nancy E. Kohl	147
17	`Gain of function' phenotype of tumor-derived mutant p53 requires the oligomerization/nonsequence-specific nucleic acid-binding domain 1998 ·Oncogene ·Árpád Lányi, (unknown), (unknown), John Ludes-Meyers, Mark A. Subler, Sumitra Deb	74
18	Transcriptional Activation of the Human Epidermal Growth Factor Receptor Promoter by Human p53 1996 ·Molecular and Cellular Biology ·John Ludes-Meyers, Mark A. Subler, (unknown), Rubén M. Muñoz, (unknown), John E. Bigger, Doris Brown, Swati Palit Deb, Sumitra Deb	152
19	Analysis of the DNA-Binding Domain of the HSV-1 Origin-Binding Protein 1994 ·Virology ·Daniel W. Martin, Raquel Muñoz, David J. Oliver, Mark A. Subler, Sumitra Deb	23
20	Regulation of c-myb oncogene expression in immature and mature murine T cells 1993 ·Molecular Immunology ·John D. Mountz, Mark A. Subler	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact